Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Diabetes Care Devices Market, by Product
1.4.2 Europe Diabetes Care Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements : 2018, Oct – 2022, May) Leading Players
Chapter 4. Europe Diabetes Care Devices Market by Product
4.1 Europe Insulin Delivery Devices Market by Country
4.2 Europe Blood Glucose Monitoring Devices Market by Country
Chapter 5. Europe Diabetes Care Devices Market by Country
5.1 Germany Diabetes Care Devices Market
5.1.1 Germany Diabetes Care Devices Market by Product
5.2 UK Diabetes Care Devices Market
5.2.1 UK Diabetes Care Devices Market by Product
5.3 France Diabetes Care Devices Market
5.3.1 France Diabetes Care Devices Market by Product
5.4 Russia Diabetes Care Devices Market
5.4.1 Russia Diabetes Care Devices Market by Product
5.5 Spain Diabetes Care Devices Market
5.5.1 Spain Diabetes Care Devices Market by Product
5.6 Italy Diabetes Care Devices Market
5.6.1 Italy Diabetes Care Devices Market by Product
5.7 Rest of Europe Diabetes Care Devices Market
5.7.1 Rest of Europe Diabetes Care Devices Market by Product
Chapter 6. Company Profiles
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Product Launches and Product Expansions:
6.2 DexCom, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Product Launches and Product Expansions:
6.2.5.3 Acquisition and Mergers:
6.3 Novo Nordisk A/S
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental & Regional Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Acquisition and Mergers:
6.4 Sanofi S.A.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Product Launches and Product Expansions:
6.5 Zealand Pharma A/S (Valeritas, Inc.)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Research & Development Expenses
6.5.4 Recent strategies and developments:
6.5.4.1 Product Launches and Product Expansions:
6.5.4.2 Approvals and Trials:
6.6 B. Braun Melsungen AG
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 Bayer AG
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Partnerships, Collaborations, and Agreements:
6.7.5.2 Approvals:
6.8 Abbott Laboratories
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.8.5 Recent strategies and developments:
6.8.5.1 Partnerships, Collaborations, and Agreements:
6.8.5.2 Approvals:
6.9 Ypsomed AG
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Recent strategies and developments:
6.9.4.1 Partnerships, Collaborations, and Agreements:
6.10. Arkray, Inc.
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Partnerships, Collaborations, and Agreements:
6.10.2.2 Geographical Expansions:



List of Tables

TABLE 1 Europe Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 2 Europe Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Diabetes Care Devices Market
TABLE 4 Product Launches And Product Expansions– Diabetes Care Devices Market
TABLE 5 Acquisition and Mergers– Diabetes Care Devices Market
TABLE 6 Geographical expansion– Diabetes Care Devices Market
TABLE 7 Approvals and Trials– Diabetes Care Devices Market
TABLE 8 Europe Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 9 Europe Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 10 Europe Insulin Delivery Devices Market by Country, 2018 - 2021, USD Million
TABLE 11 Europe Insulin Delivery Devices Market by Country, 2022 - 2028, USD Million
TABLE 12 Europe Blood Glucose Monitoring Devices Market by Country, 2018 - 2021, USD Million
TABLE 13 Europe Blood Glucose Monitoring Devices Market by Country, 2022 - 2028, USD Million
TABLE 14 Europe Diabetes Care Devices Market by Country, 2018 - 2021, USD Million
TABLE 15 Europe Diabetes Care Devices Market by Country, 2022 - 2028, USD Million
TABLE 16 Germany Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 17 Germany Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 18 Germany Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 19 Germany Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 20 UK Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 21 UK Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 22 UK Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 23 UK Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 24 France Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 25 France Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 26 France Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 27 France Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 28 Russia Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 29 Russia Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 30 Russia Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 31 Russia Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 32 Spain Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 33 Spain Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 34 Spain Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 35 Spain Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 36 Italy Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 37 Italy Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 38 Italy Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 39 Italy Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 40 Rest of Europe Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 41 Rest of Europe Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 42 Rest of Europe Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 43 Rest of Europe Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 44 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 45 Key Information – DexCom, Inc.
TABLE 46 Key information – Novo Nordisk A/S
TABLE 47 Key Information – Sanofi S.A.
TABLE 48 Key Information – Zealand Pharma A/S
TABLE 49 key Information – B. Braun Melsungen AG
TABLE 50 Key Information – Bayer AG
TABLE 51 Key Information – Abbott Laboratories
TABLE 52 Key Information –-Ypsomed AG
TABLE 53 Key Information – Arkray, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, collaborations and agreements : 2018, oct – 2022, may) Leading Players
FIG 5 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 6 Recent strategies and developments: DexCom, Inc.
FIG 7 Recent strategies and developments: Novo Nordisk A/S
FIG 8 Recent strategies and developments: Sanofi S.A.
FIG 9 Recent strategies and developments: Zealand Pharma A/S
FIG 10 Recent strategies and developments: Arkray, Inc.